Effect of homeopathic treatment on gene expression in Copenhagen rat tumor tissues

Integrative Cancer Therapies

Volumn 5, Issue 4, 2006, Pages 350-355

  Thangapazham, Rajesh L ^a,b   Rajeshkumar, N V ^a   Sharma, Anuj ^a,b   Warren, Jim ^a   Singh, Anoop K ^a   Ives, John A ^c   Gaddipati, Jaya P ^a   Maheshwari, Radha K ^a   Jonas, Wayne B ^c  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

^c SAMUELI INSTITUTE   (United States)

Author keywords

Apoptosis; Carcinosin; Copenhagen rats; Cytokines; Homeopathy; MAT LyLu; Metastasis

Indexed keywords

CASPASE 2; CASPASE 3; CYTOKINE; FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONIUM; CONTROLLED STUDY; GENE EXPRESSION; HOMEOPATHY; NONHUMAN; PRIORITY JOURNAL; PROSTATE CARCINOMA; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SABAL;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CYTOKINES; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEOPATHY; MALE; PHYTOTHERAPY; PROSTATIC NEOPLASMS; RATS; RATS, INBRED STRAINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 33750853598     PISSN: 15347354     EISSN: 1552695X     Source Type: Journal    
DOI: 10.1177/1534735406294226     Document Type: Article

References (23)

1. McCloskey D, Armstrong D, Jackisch C, Davidson N. Programmed cell death in human breast cancer cells. Recent Prog Horm Res. 1996;51:493-508.
2. Tang DG, Porter AT. Target to apoptosis: a hopeful weapon for prostate cancer. Prostate. 1997;32:284-293.
3. Boedefeld WM II, Bland KI, Heslin MJ. Recent insights into angiogenesis, apoptosis, invasion, and metastasis in colorectal carcinoma. Ann Surg Oncol. 2003;10:839-851.
4. Johnson MI, Hamdy FC. Apoptosis regulating genes in prostate cancer. Oncol Rep. 1998;5:553-557.
5. Jonas WB, Gaddipati JP, Rajeshkumar NV, et al. In vitro and in vivo assessment of homeopathic treatment for prostate cancer. Paper presented at: Society of Integrative Oncology First International Conference; November 18, 2004; New York, NY.
6. Heine H, Schmolz M. Immunoregulation via "bystander suppression" needs minute amounts of substances - a basis for homeopathic therapy? Med Hypotheses. 2000;54:392-393.
7. Jonas WB, Gaddipati JP, Rajeshkumar NV, et al. Can homeopathic treatment slow prostate cancer growth? Integ Cancer Ther. 2006;5:343-349.
8. Jonas WB. The homeopathy debate. J Altern Complement Med. 2000;6:213-215.
9. Shang A, Huwiler-Muntener K, Nartey L, et al. Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy. Lancet. 2005;366:726-732.
10. Cambar J, Delbancut A, Barrouillet M. Effects of metal dilutions on cells and integrated systems. In: Taddei-Ferretti C, ed. High Dilution Effects on Cells and Integrated Systems. Hong Kong: World Scientific Editions; 1998:45-62.
11. Wiegant F, van Rijn J, van Wijk R. Enhancement of the stress response by minute amounts of cadmium in sensitized Reuber H35 hepatoma cells. Toxicology. 1997;116:27-37.
12. Linde K, Jonas W B, Melchart D, Worku F, Wagner H, Eitel F. Critical review and meta-analysis of serial agitated dilutions in experimental toxicology. Hum Exp Toxicol. 1994;13:481-492.
13. Goering P, Waalkes M, Klaassen C. Cadmium toxicity. In: Goyer R, Cherian M, eds. Handbook of Experimental Pharmacology; Toxicology of Metals, Biochemical Effects. New York, NY: Springer-Verlag; 1994.
14. Cambar J, Delbancut A, Barrouillet M. Effects of cadmium very high dilutions in renal tubular cell cultures. In: Taddei-Ferretti C, ed. High Dilution Effects on Cells and Integrated Systems. Hong Kong: World Scientific Editions; 1998:107-115.
15. Soignet SL, Maslak P, Wang ZG, et al. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med. 1998;339:1341-1348.
16. Che G, Zhu J, Shia X. In vitro studies on cellular and molecular mechanisms of arsenic trioxide in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cells apoptosis with down regulation of Bcl2 expression and modulation of PML-RAR alpha/PML proteins. Blood. 1996;88:1051-1061.
17. Shao W, Fanelli M, Ferrara FF, et al. Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cells. J Natl Cancer Inst. 1998;90:124-133.
18. Tsuchitani T, Zighelboim J, Beker J, Bonavida B. Potentiation of cytotoxicity against human ovarian cell lines with combination of sub toxic concentrations of tumor necrosis factor and adriamycin or cisplatinum. J Cell Pharmacol. 1991;2:1-11.
19. Palmieri G, Montella L, Milo M, et al. Ultra-low-dose interleukin-2 in unresectable hepatocellular carcinoma. Am J Clin Oncol. 2002;25:224-226.
20. Brack A, Strube J, Stolz P, Decker H. Effects of ultrahigh dilutions of 3,5-dichlorophenol on the luminescence of the bacterium Vibrio fischeri. Biochim Biophys Acta. 2003;1621:253-260.
21. Linde K, Jonas W. Are the clinical effects of homoeopathy placebo effects? Lancet. 2005;366:2081-2082, 2083-2086.
22. Thangapazham RL, Gaddipati JP, Rajeshkumar NV, et al. Homeopathic medicines do not alter growth and gene expression in prostate and breast cancer cells in vitro. Integ Cancer Ther. 2006;5:356-361.
23. Winter RN, Kramer A, Borkowski A, Kyprianou N. Loss of caspase-1 and caspase-3 protein expression in human prostate cancer. Cancer Res. 2001;61:1227-1232.